Home›Companies›Biotech & Pharma›65 Therapeutics

65 Therapeutics, Inc.

No website or LinkedIn page we could confirm. Why?
Updated Nov 10, 2026·Latest SEC filing Jul 6, 2026·Suggest an edit

About 65 Therapeutics

65 Therapeutics is a private company based in Somerville, Massachusetts, incorporated in 2024 in Delaware. It has reported $6,700,000 raised in one offering on Form D since December 2024.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 21, 2024Dec 6, 2024amended Jul 6, 2026$6,700,000fully sold2$3.3MEquityRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on 65 Therapeutics's Form D filed Jul 6, 2026.

MC
JK
Julius Knowles
President and director

Sources

  1. SEC65 Therapeutics, Inc. Form D, filed Dec 6, 2024
  2. SEC65 Therapeutics, Inc. filing history